Clinical trial · Observational
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
GENEWING - A Genome Wide Association Study in Ewing Sarcoma
NCT01210209CI-TRIAL-00051884GENEWINGcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| genome-wide association study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Identification and characterization of susceptibility genes in patients with Ewing sarcoma
- timeFrame
- Through study completion, an average of 10 years
- description
- Identification and characterization of susceptibility genes in patients with Ewing sarcoma
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Patients with Ewing sarcoma * Relatives of Ewing sarcoma patients PATIENT CHARACTERISTICS: * Patients with a fusion genes specific of Ewing Sarcoma PRIOR CONCURRENT THERAPY: * Not applicable
References
Publications (0)
Data not yet available
No reference posted for this study.